BURKITTS-LYMPHOMA - A MODEL FOR CLINICAL ONCOLOGY

被引：24

作者：

BOUFFET, E

FRAPPAZ, D

PINKERTON, R

FAVROT, M

PHILIP, T

机构：

[1] CTR LEON BERARD,DEPT PEDIAT ONCOL,28 RUE LAENNEC,F-69008 LYONS,FRANCE

[2] ROYAL MARSDEN HOSP,DEPT PEDIAT ONCOL,SUTTON SM2 5PX,SURREY,ENGLAND

[3] HOP NORD ST PRIEST JAREZ,DEPT PEDIAT,ST PRIEST JAREZ,FRANCE

来源：

EUROPEAN JOURNAL OF CANCER | 1991年 / 27卷 / 04期

关键词：

D O I：

10.1016/0277-5379(91)90397-V

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Burkitt's lymphoma, a pathological entity initially described in Africa, is the most common childhood lymphoma in western countries and represents approximately 5% of all adults lymphomas. This high grade small non-cleaved diffuse lymphoma is a model with which to study the relations between cancer and viruses, the chromosomes and the genes. Burkitt's lymphoma is also a model for clinical research which allows evaluation of the dose effect concept with chemotherapy and the role of megatherapy with autologous bone marrow rescue.

引用

页码：504 / 509

页数：6

共 64 条

[51] HIGH-DOSE THERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN PARTIAL REMISSION AFTER 1ST-LINE INDUCTION THERAPY FOR DIFFUSE NON-HODGKINS LYMPHOMA [J].

PHILIP, T ;

HARTMANN, O ;

BIRON, P ;

CAHN, JY ;

PEIN, F ;

BORDIGONI, P ;

SOUILLET, G ;

GARTNER, M ;

LASSET, C ;

CHAUVIN, F .

JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (07) :1118-1124

[52] EFFECTIVE MULTIAGENT CHEMOTHERAPY IN CHILDREN WITH ADVANCED B-CELL LYMPHOMA - WHO REMAINS THE HIGH-RISK PATIENT [J].

PHILIP, T ;

PINKERTON, R ;

BIRON, P ;

LADJADJ, Y ;

BOUFFET, E ;

SOUILLET, G ;

PHILIPPE, N ;

FRAPPAZ, D ;

FREYCON, F ;

CHAUVIN, F ;

BRUNATMENTIGNY, M .

BRITISH JOURNAL OF HAEMATOLOGY, 1987, 65 (02) :159-164

[53] BURKITT-TYPE LYMPHOMA IN FRANCE AMONG NON-HODGKIN MALIGNANT-LYMPHOMAS IN CAUCASIAN CHILDREN [J].

PHILIP, T ;

LENOIR, GM ;

BRYON, PA ;

GERARDMARCHANT, R ;

SOUILLET, G ;

PHILIPPE, N ;

FREYCON, F ;

BRUNATMENTIGNY, M .

BRITISH JOURNAL OF CANCER, 1982, 45 (05) :670-678

[54] HIGH-DOSE THERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION AFTER FAILURE OF CONVENTIONAL CHEMOTHERAPY IN ADULTS WITH INTERMEDIATE-GRADE OR HIGH-GRADE NON-HODGKINS-LYMPHOMA [J].

PHILIP, T ;

ARMITAGE, JO ;

SPITZER, G ;

CHAUVIN, F ;

JAGANNATH, S ;

CAHN, JY ;

COLOMBAT, P ;

GOLDSTONE, AH ;

GORIN, NC ;

FLESH, M ;

LAPORTE, JP ;

MARANINCHI, D ;

PICO, J ;

BOSLY, A ;

ANDERSON, C ;

SCHOTS, R ;

BIRON, P ;

CABANILLAS, F ;

DICKE, K .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (24) :1493-1498

[55] THE ROLE OF MASSIVE THERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN BURKITTS-LYMPHOMA [J].

PHILIP, T ;

PINKERTON, R ;

HARTMANN, O ;

PATTE, C ;

PHILIP, I ;

BIRON, P ;

FAVROT, M .

CLINICS IN HAEMATOLOGY, 1986, 15 (01) :205-217

[56]

PHILIP T, 1985, BURKITTS LYMPHOMA HU, P465

[57]

PHILIP T, 1988, 20 M INT SOC PAED ON

[58]

PHILIP T, 1985, BURKITTS LYMPHOMA HU, P107

[59] SURFACE BOUND IMMUNOGLOBULINS AS A CELL MARKER IN HUMAN LYMPHOPROLIFERATIVE DISEASES [J].

PREUDHOMME, JL ;

SELIGMANN, M .

BLOOD-THE JOURNAL OF HEMATOLOGY, 1972, 40 (06) :777-+

[60]

RODARY C, 1988, 20 M INT SOC PAED ON

← 1 2 3 4 5 6 7 →